Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain

BACKGROUND/PURPOSE: NGX-4010 (QUTENZA(™); NeurogesX Inc, San Mateo, CA), a capsaicin 8% dermal patch, is licensed in the European Union for the treatment of peripheral neuropathic pain (PNP) in nondiabetic adults and in the United States for the treatment of neuropathic pain associated with postherp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Peppin, John F, Majors, Kristine, Webster, Lynn R, Simpson, David M, Tobias, Jeffrey K, Vanhove, Geertrui F
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2011
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3255992/
https://ncbi.nlm.nih.gov/pubmed/22247621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S22954
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados